Advocacy News
The ACR is your source for advocacy news impacting your practice, patients, and the rheumatology subspecialty. In addition to staying on top of ever-changing policies and political landscapes for our members, we are often invited to give statements, provide comments, or work with lawmakers to promote new policies.
For the most up to date news regarding ACR advocacy efforts, be sure to follow @ACRheumDC on Twitter.
New Resource: Understanding the New Medicare G2211 Code
Download the ACR educational guide and frequently asked questions for the new Medicare-specific add on code G2211 which addresses the complexity inherent to office and outpatient evaluation and management services.
Quarterly Advocacy Update
The ACR advocacy team has been hard at work! Not every piece of legislation, regulatory policy, or state issue makes it into a headline, but we have collected the actions of our team over the course of 2024 into one place for ACR/ARP members to stay up to date.
Read Quarterly Advocacy Update
Advocacy Priorities
See an overview of the ACR’s Policy Priorities for the U.S. Congress, federal agencies, and state governments.
Press & Public Statements
View the latest rheumatology news, including press releases and public statements about current advocacy issues affecting ACR and ARP membership in the Press Room.
ACR@Work Newsletter
The ACR publishes a bimonthly electronic newsletter for members with the latest news and activities relating to advocacy and policy updates, practice management, insurance issues, and more. See the latest issues.
September 26, 2024 – Advocacy that Benefits Practices, Help with E/M Downcoding & More
September 12, 2024 – The ACR's Comments on the PFS Proposed Rule, RDAM & More
August 22, 2024 – Biosimilar Switching, Practice Resources & Capitol Hill Meetings
August 8, 2024 – Maintaining Reimbursement for Complex Care, Biosimilars & More
Social Media
Be sure to follow the ACR on Facebook, X, Instagram, and LinkedIn. For advocacy specific updates, follow @ACRheumDC on Twitter. ACR often interacts with lawmakers, posts pictures, circulates articles, and more. Get engaged and join the conversation.